Market Cap 1.67M
Revenue (ttm) 6.77M
Net Income (ttm) -53.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -788.18%
Debt to Equity Ratio 0.14
Volume 619,115
Avg Vol 1,317,249
Day's Range N/A - N/A
Shares Out 4.62M
Stochastic %K 12%
Beta -0.56
Analysts Strong Buy
Price Target $11.00

Company Profile

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics t...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 215 345 0919
Address:
711 Stewart Avenue, Suite 200, Garden City, United States
SpartanTrader117
SpartanTrader117 Feb. 23 at 5:57 PM
0 · Reply
_8xSasuke
_8xSasuke Feb. 23 at 12:20 PM
0 · Reply
VickieWaldron193
VickieWaldron193 Feb. 21 at 7:38 AM
$PRPH ProPhase Labs operates diagnostics and consumer health assets. Revenue diversification is improving. Execution risk remains.
0 · Reply
johannn
johannn Feb. 20 at 11:46 PM
$PRPH It was to be expected that the reverse merger would not go through. So no millions to be distributed among the shareholders. https://www.webdisclosure.com/press-release/abl-diagnostics-epa-abld-inside-information-other-news-releases-JqomX61GhNB 🥷🥷🕵️🕵️
0 · Reply
_Sasuke10x
_Sasuke10x Feb. 19 at 5:31 PM
0 · Reply
_8xSasuke
_8xSasuke Feb. 18 at 12:29 PM
0 · Reply
2xSasuke
2xSasuke Feb. 17 at 6:11 PM
0 · Reply
Tdavis_19
Tdavis_19 Feb. 17 at 6:00 PM
$PRPH what’s up with this?
0 · Reply
_8xSasuke
_8xSasuke Feb. 17 at 1:03 PM
0 · Reply
GuruChartist
GuruChartist Feb. 16 at 6:38 PM
$PRPH Impact Biomedical $IBO owns the rights to Equivir. PRPH just licensed it and is supposed to advance it to the market so that Impact Biomedical can pay them royalties.
0 · Reply
Latest News on PRPH
No data available.
SpartanTrader117
SpartanTrader117 Feb. 23 at 5:57 PM
0 · Reply
_8xSasuke
_8xSasuke Feb. 23 at 12:20 PM
0 · Reply
VickieWaldron193
VickieWaldron193 Feb. 21 at 7:38 AM
$PRPH ProPhase Labs operates diagnostics and consumer health assets. Revenue diversification is improving. Execution risk remains.
0 · Reply
johannn
johannn Feb. 20 at 11:46 PM
$PRPH It was to be expected that the reverse merger would not go through. So no millions to be distributed among the shareholders. https://www.webdisclosure.com/press-release/abl-diagnostics-epa-abld-inside-information-other-news-releases-JqomX61GhNB 🥷🥷🕵️🕵️
0 · Reply
_Sasuke10x
_Sasuke10x Feb. 19 at 5:31 PM
0 · Reply
_8xSasuke
_8xSasuke Feb. 18 at 12:29 PM
0 · Reply
2xSasuke
2xSasuke Feb. 17 at 6:11 PM
0 · Reply
Tdavis_19
Tdavis_19 Feb. 17 at 6:00 PM
$PRPH what’s up with this?
0 · Reply
_8xSasuke
_8xSasuke Feb. 17 at 1:03 PM
0 · Reply
GuruChartist
GuruChartist Feb. 16 at 6:38 PM
$PRPH Impact Biomedical $IBO owns the rights to Equivir. PRPH just licensed it and is supposed to advance it to the market so that Impact Biomedical can pay them royalties.
0 · Reply
rammar_invests
rammar_invests Feb. 15 at 12:51 PM
$PRPH He's been yapping about great progress since January 2025, draw your own conclusions.
0 · Reply
Undisclosed07
Undisclosed07 Feb. 13 at 2:19 PM
$PRPH did anyone believe what ted said about crown or is it more bs from the snake oil salesman. If true would be massive
0 · Reply
Invest4_life
Invest4_life Feb. 10 at 1:06 AM
$PRPH Took entry of 50k usd worth today on this shit. I see an early break out.
1 · Reply
johannn
johannn Feb. 6 at 11:24 AM
$PRPH Equivir (OTC): The study demonstrates a clinically studied dietary supplement with significant potential. Commercialization to be determined. Aha, now Equivir is being used as bait again. According to Ted, it used to be worth billions in his many hours of storytelling. And who is the long-time loyal investor that Ted is so disappointed in, I think? ThinkEquity https://ap.lc/EpjDN.🕵️‍♂️🕵️‍♂️🥷🥷🦮🦮 https://d1io3yog0oux5.cloudfront.net/_16a77ab1cb06df0ad21347ebff0e0976/prophaselabs/db/1323/12302/pdf/ProPhase+Labs+Presentation+%28Website+Version%29+2026-0205.pdf
0 · Reply
Infovester
Infovester Feb. 5 at 4:55 PM
$PRPH sooo who’s the long term investor that turned on Ted? I’d like to know…
1 · Reply
johannn
johannn Feb. 4 at 10:11 AM
$PRPH For those who missed the fairy tale/liar story, here's the replay. https://www.youtube.com/watch?v=rbFE66jf0gw
1 · Reply
johannn
johannn Feb. 3 at 10:16 PM
$PRPH Lots of rambling and lots of different/contradictory statements, and no answer to my question. 🧸🧸🧸🧸
0 · Reply
stevero
stevero Feb. 3 at 9:50 PM
$PRPH Ted just avoided the question of the current outstanding number of shares.
1 · Reply
johannn
johannn Feb. 3 at 6:46 PM
$PRPH I've sent a question, let's see if we get an answer soon. Will the reverse merger with ABL still go ahead now that Prophase is no longer listed on the Nasdaq?
1 · Reply
AdLucrum
AdLucrum Feb. 3 at 12:05 PM
$PRPH https://ir.prophaselabs.com/news-events/press-releases/detail/264/prophase-labs-initiates-potential-sale-or-strategic
0 · Reply
AdLucrum
AdLucrum Feb. 3 at 9:43 AM
$PRPH I will be interested in attending the Investor Webinar later today. I hope that if and when the turnaround comes, it will match $GLSI.
0 · Reply
stevero
stevero Feb. 3 at 6:19 AM
$PRPH Please don't confuse ProPhase's Teddy aka Theodore in any way, shape, or form with Alvin and the Chipmunks State of the Art Lozenger Laboratory. “THEOOOOODORE!”
0 · Reply